BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 21906147)

  • 1. Sturge-Weber syndrome in patients with facial port-wine stain.
    Piram M; Lorette G; Sirinelli D; Herbreteau D; Giraudeau B; Maruani A
    Pediatr Dermatol; 2012; 29(1):32-7. PubMed ID: 21906147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of risk for Sturge-Weber syndrome in children with upper facial port-wine stain.
    Dutkiewicz AS; Ezzedine K; Mazereeuw-Hautier J; Lacour JP; Barbarot S; Vabres P; Miquel J; Balguerie X; Martin L; Boralevi F; Bessou P; Chateil JF; Léauté-Labrèze C;
    J Am Acad Dermatol; 2015 Mar; 72(3):473-80. PubMed ID: 25592619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facial port-wine stains - clinical stratification and risks of neuro-ocular involvement.
    Ch'ng S; Tan ST
    J Plast Reconstr Aesthet Surg; 2008 Aug; 61(8):889-93. PubMed ID: 17604243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Facial angioma and the Sturge-Weber syndrome: a study of 121 cases].
    Bioxeda P; de Misa RF; Arrazola JM; Pérez B; Harto A; Ledo A
    Med Clin (Barc); 1993 May; 101(1):1-4. PubMed ID: 8315969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periocular port wine stain: the great ormond street hospital experience.
    Khaier A; Nischal KK; Espinosa M; Manoj B
    Ophthalmology; 2011 Nov; 118(11):2274-2278.e1. PubMed ID: 21783256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 12-year retrospective study of Sturge-Weber syndrome and literature review.
    Sinawat S; Auvichayapat N; Auvichayapat P; Yospaiboon Y; Sinawat S
    J Med Assoc Thai; 2014 Jul; 97(7):742-50. PubMed ID: 25265774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sturge-Weber syndrome].
    Maruani A
    Presse Med; 2010 Apr; 39(4):482-6. PubMed ID: 20219318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forehead location and large segmental pattern of facial port-wine stains predict risk of Sturge-Weber syndrome.
    Boos MD; Bozarth XL; Sidbury R; Cooper AB; Perez F; Chon C; Paras G; Amlie-Lefond C
    J Am Acad Dermatol; 2020 Oct; 83(4):1110-1117. PubMed ID: 32413446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Factors for Epilepsy in Pediatric Patients With Sturge-Weber Syndrome.
    Kaseka ML; Bitton JY; Décarie JC; Major P
    Pediatr Neurol; 2016 Nov; 64():52-58. PubMed ID: 27637568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sturge-Weber syndrome in port-wine stain patients: a retrospective study on the clinical features and screening strategy].
    Wu Y; Yu RJ; Lin XX; Guo WY
    Zhonghua Yan Ke Za Zhi; 2017 Oct; 53(10):753-757. PubMed ID: 29050188
    [No Abstract]   [Full Text] [Related]  

  • 11. Physical and Family History Variables Associated With Neurological and Cognitive Development in Sturge-Weber Syndrome.
    Day AM; McCulloch CE; Hammill AM; Juhász C; Lo WD; Pinto AL; Miles DK; Fisher BJ; Ball KL; Wilfong AA; Levin AV; Thau AJ; Comi AM; ; Koenig JI; Lawton MT; Marchuk DA; Moses MA; Freedman SF; Pevsner J
    Pediatr Neurol; 2019 Jul; 96():30-36. PubMed ID: 30853154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective review of screening for Sturge-Weber syndrome with brain magnetic resonance imaging and electroencephalography in infants with high-risk port-wine stains.
    Zallmann M; Mackay MT; Leventer RJ; Ditchfield M; Bekhor PS; Su JC
    Pediatr Dermatol; 2018 Sep; 35(5):575-581. PubMed ID: 30020536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sturge-Weber syndrome and dermatomal facial port-wine stains: incidence, association with glaucoma, and pulsed tunable dye laser treatment effectiveness.
    Hennedige AA; Quaba AA; Al-Nakib K
    Plast Reconstr Surg; 2008 Apr; 121(4):1173-1180. PubMed ID: 18349634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and Neuroimaging Analysis of 24 Cases of Sturge-Weber Syndrome].
    Li YM; Liu C; Cong TX; Zhang HY; Zhou H; Zhao Q; Jiang X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 51(4):562-566. PubMed ID: 32691568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trigeminal dermatome distribution in patients with glaucoma and facial port wine stain.
    Mehta M; Salas AH; Fay A
    Dermatology; 2009; 219(3):219-24. PubMed ID: 19672053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of infants with port-wine stain and glaucoma secondary to Sturge-Weber Syndrome.
    Yan H; Hu M; Cui Y; Li L; Liang T
    BMC Ophthalmol; 2022 Jun; 22(1):260. PubMed ID: 35681114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Sturge-Weber syndrome and associated ocular involvement in Olmsted County, Minnesota, United States.
    Rihani HT; Dalvin LA; Hodge DO; Pulido JS
    Ophthalmic Genet; 2020 Apr; 41(2):108-124. PubMed ID: 32233696
    [No Abstract]   [Full Text] [Related]  

  • 18. Facial Port-Wine Stain Phenotypes Associated with Glaucoma Risk in Neonates.
    Ha A; Kim JS; Baek SU; Park YJ; Jeoung JW; Park KH; Kim YK
    Am J Ophthalmol; 2020 Dec; 220():183-190. PubMed ID: 32795435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematoporphyrin monomethyl ether photodynamic therapy for the treatment of Sturge-Weber syndrome and large segmental facial port-wine stain.
    Li X; Diao P; Liu L; Zhou H; Yang Y; Han C; Jiang X
    Dermatol Ther; 2022 May; 35(5):e15404. PubMed ID: 35199900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A spectrum of unusual neuroimaging findings in patients with suspected Sturge-Weber syndrome.
    Adams ME; Aylett SE; Squier W; Chong W
    AJNR Am J Neuroradiol; 2009 Feb; 30(2):276-81. PubMed ID: 19050205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.